VITAL to Distribute Imagine Eyes’ rtx1™ Adaptive Optics Retinal Camera in Japan
News Oct 29, 2012
Imagine Eyes and VITAL Corporation have announced that VITAL will distribute Imagine Eyes’ rtx1™ Adaptive Optics Retinal Camera in Japan.
“VITAL has a proud history of identifying novel medical technologies that benefit doctors and patients alike” states Masao Ichinoseki, President of VITAL Corporation.
Ichinoseki continued, “Imagine Eyes’ retinal camera recently received Shonin (NINSHO) approval from the Japanese Ministry of Health, Labor and Welfare and can now enable Japanese ophthalmologists to visualize their patients’ retinas in unparalleled detail. We hope that this will allow them to enhance the quality of care they provide and help them save vision.”
“Japan is the world’s second largest market for medical devices after the Unites States” remarks Tomoki Tateishi, Marketing Director at VITAL Corporation.
Tateishi continued, “Historically, VITAL uses an effective strategy based in part on inviting leading experts in their field to come and present their experience with the cutting-edge medical devices we supply especially in interventional cardiology and cardiovascular surgery. We will use a similar approach as part of marketing the rtx1 Adaptive Optics Retinal Camera in Japan and we expect to see rapid adoption by ophthalmologists across the country. The first such event will be held on October 26, 2012, and will spotlight the work of both French and Japanese researchers that use the rtx1.”
“Several leading Japanese researchers embraced the rtx1’s cellular-level-retinal-imaging abilities very early on, and we are very thankful to them for their support as it has been instrumental in creating demand in their country” says Nicolas Chateau, Imagine Eyes’ Cofounder and CEO.
Chateau continued, “We look forward to working with VITAL to provide Japanese ophthalmologists with a new tool that will help further sight-saving research today and potentially improve the already impressive healthcare citizens receive in the future.”
VITAL provides demonstrations of the rtx1 Adaptive Optics Retinal Camera in room E at the 66th Annual Japanese Clinical Ophthalmology Congress in Kyoto Japan from October 25-28, 2012.
Researchers Reveal How Superbug Secretes It’s ToxinNews
Monash University’s Biomedicine Discovery Institute (BDI) researchers have created the first high-resolution structure depicting a crucial part of the ‘superbug’ Pseudomonas aeruginosa. The image identifies the ‘nanomachine’ used by the highly virulent bacteria to secrete toxins, pointing the way for drug design targeting this.READ MORE
New Drug Class: Potential Therapeutics for Alzheimer’s Disease?News
One step closer to an Alzheimer's treatment? Novel class of drugs more precisely blocks production of toxic forms of beta-amyloid.READ MORE
Survival Trait Evolution Shown in 54 Million-Year-Old Sea TurtleNews
High-resolution analytical techniques of pigment, beta-keratin and muscle proteins from a 54 million-year-old sea turtle hatchling revealed that a pigment-based survival trait common to modern sea turtles evolved at least 54 million years ago.READ MORE